Sponsored by:

Nuclear Medicine: Page 394

Molecular imaging explains why ibuprofen prevents Alzheimer’s
By Tracie L. Thompson
A new radiotracer under development at UCLA has enabled researchers to see for the first time how NSAIDs appear to prevent and even dissolve the amyloid plaque brain lesions that characterize, and likely cause, Alzheimer’s disease.
April 7, 2003
Dopamine transporter imaging with SPECT narrows Parkinsonian diagnosis
Dopamine transporter imaging using 123I beta-CIT SPECT may improve the accuracy of Parkinsonian syndrome diagnosis, according to a report from the American Academy of Neurology (AAN) meeting last week in Honolulu.
April 6, 2003
DraxImage begins U.S. shipments of I-131 kit
By AuntMinnie.com staff writers
Radiopharmaceutical firm Draxis Health division DraxImage has initiated U.S. shipments of its recently approved radiotherapeutic product, a kit for the preparation of sodium iodide I-131 capsules and oral solution.
April 2, 2003
Berlex suspends NeoTect production and sales
By Robert Bruce
Contrast maker Berlex Imaging notified customers that it has suspended production of peptide-based radiopharmaceutical NeoTect until it resolves quality control issues at its European plant.
March 27, 2003
RSI, Siemens ink distribution deal
By AuntMinnie.com staff writers
RSI's Watsyn software development platform will be added to Siemens' e.soft nuclear medicine workstation software.
March 9, 2003
PET makes progress in documenting movement disorders
By Paula Moyer
Neuroimaging advances are playing a critical role in the understanding of movement disorders. PET in particular is proving invaluable for assessing a wide range of clinical issues ranging from presymptomatic changes to treatment-related complications, according to researchers at the International Congress of Parkinson’s Disease and Movement Disorders in Miami.
March 3, 2003
2003 03 03 16 24 44 706
Single-Photon Emission Computed Tomography (SPECT): A Primer
This book addresses the basic subjects of SPECT imaging, but adds technical information not readily found in other basic textbooks, or for that matter, in journal articles.
February 27, 2003
Cytogen 2002 loss grows despite revenue gains
By AuntMinnie.com staff writers
Biopharmaceutical firm Cytogen reported 2002 revenue of $12.5 million, up 15% from the $10.9 million posted in 2001.
February 25, 2003
Physician groups navigate a rocky road to PET reimbursement
By Jonathan S. Batchelor
The Centers for Medicare and Medicaid Services (CMS) will update its policies for PET reimbursement next week. Ruth Tesar, executive director of Northern California PET Imaging in Sacramento, traces PET imaging's complicated reimbursement history.
February 25, 2003
NAS shows sales uptick
By AuntMinnie.com staff writers
Radiopharmaceutical developer North American Scientific reported first-quarter sales of $5.1 million, up 4% from the $4.9 million posted in the first quarter of 2002.
February 24, 2003
Neoprobe shows loss in 2002
By AuntMinnie.com staff writers
Radiopharmaceutical probe developer Neoprobe of Dublin, OH, has reported losses in both its fourth quarter and fiscal 2002 (end-December 31, 2002).
February 19, 2003
Siemens signs UCLA
By AuntMinnie.com staff writers
Siemens Medical Solutions of Malvern, PA, will be providing three Oncor Impression linear accelerators to the University of California, Los Angeles (UCLA) Medical Center.
February 18, 2003
Previous Page
Page 394 of 439
Next Page